Ginger and 6-shogaol protect intestinal tight junction and enteric dopaminergic neurons against 1-methyl-4-phenyl 1, 2, 3, 6-tetrahydropyridine in mice. (2nd June 2020)

• Record Type: Journal Article
• Authors: Huh, Eugene; Choi, Jin Gyu; Noh, Dongjin; Yoo, Hyung-Seok; Ryu, Jeewon; Kim, Nam-Jung; Kim, Hocheol; Oh, Myung Sook
• Is Part Of: Nutritional neuroscience. Volume 23:Number 6(2020)
• Page Start: 455
• Page End: 464
• Publication Date: 2020-06-02
• Subjects: Ginger -- 6-shogaol -- Parkinson's disease -- Intestinal barrier -- Enteric dopaminergic neuron -- 1-methyl-4-phenyl 1, 2, 3, 6-tetrahydropyridine; Neuropharmacology -- Periodicals; Diet -- Periodicals; Diet therapy -- Periodicals; Nutrition -- Periodicals; 615.78
• DOI: 10.1080/1028415X.2018.1520477
• Languages: English
• ISSNs: 1028-415X

Abstract

Abstract : Objective: Ginger and its compound, 6-shogaol, have been known for improving gastrointestinal (GI) function and reducing inflammatory responses in GI tract. Recently, the treatment of GI dysfunction has been recognized as an important part of the management of neurodegenerative diseases, especially for Parkinson's disease (PD). In this study, we investigated whether ginger and 6-shogaol attenuate disruptions induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on the intestinal barrier and the enteric dopaminergic neurons. Methods: C57BL/6J mice received MPTP (30 mg/kg) for 5 days to induce GI alterations. Ginger (30, 100, 300 mg/kg) and 6-shogaol (10 mg/kg) were treated by gavage feeding for 15 days including the period of MPTP injection. Results: Ginger and 6-shogaol protected intestinal tight junction proteins disrupted by MPTP in mouse colon. In addition, ginger and 6-shogaol suppressed the increase of inducible nitric oxide synthase, cyclooxygenase-2, TNF-α and IL-1β activated by macrophage. Moreover, ginger and 6-shogaol suppressed the MPTP-induced enteric dopaminergic neuronal damage via increasing the cell survival signaling pathway. Conclusion: These results indicate that ginger and 6-shogaol restore the disruption of intestinal integrity and enteric dopaminergic neurons in an MPTP-injected mouse PD model by inhibiting the processes of inflammation and apoptosis, suggesting that they may attenuate the GI dysfunction in PD patients.